https://preview.redd.it/03rw99qzwuea1.png?width=557&format=pjpg&auto=webp&v=enabled&s=392c379b92150accf7352b0872b68ca0028e68a4

Abbvie has had the Humira patent since 2002 I believe, (remember 43% of sales last year) does this chart really show an adequate correction for losing a monopoly on 43% of sales?

If you look at their price, I'd say it's fairly obvious that it has not been priced in... But hey... I'll tell you what, if you feel confident it's priced in buy one share of Abbvie and hold it until February 14th. If you're right you can sell it and nothing will happen.

https://www.biostock.se/en/2022/12/several-blockbuster-patents-to-expire-in-2023/#:~:text=The%20main%20patent%20for%20Humira,product%20well%20into%20the%20future.

Here is a non-paywall article. It also mentions that Humira accounted for 43% of Abbvie's sales last year.

I'll see what I can find